
    Original Text: Progression of tumor or intolerance to therapies known to provide clinical benefit. There is no limit to the number of prior treatment regimens
    Disease/Condition: none
    Procedure: none
    Drug: none
    Biomarker: none
    Computable Rule: "Progression of tumor or intolerance to therapies known to provide clinical benefit." is False

Criterion:
    Patients with metastatic breast cancer who have progressed on at least one chemotherapy regimen for advanced disease, including anthracycline-and taxane-based regimens, and who have received no more than two chemotherapy regimens for metastatic disease

Output:
    Original Text: Patients with metastatic breast cancer who have progressed on at least one chemotherapy regimen for advanced disease, including anthracycline-and taxane-based regimens, and who have received no more than two chemotherapy regimens for metastatic disease
    Disease/Condition: Breast Cancer
    Procedure: Anthracycline-and